2,3-Dihydroxypropyl oleate is a lipid of Glycerolipids (GL) class. The involved functions are known as enzyme activity and acyltransferase activity. 2,3-dihydroxypropyl oleate often locates in soluble fraction.
To understand associated biological information of 2,3-Dihydroxypropyl oleate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
There are no associated biomedical information in the current reference collection.
We collected disease MeSH terms mapped to the references associated with 2,3-Dihydroxypropyl oleate
| MeSH term | MeSH ID | Detail |
|---|---|---|
| Blood Loss, Surgical | D016063 | 6 associated lipids |
| Hypertension, Renovascular | D006978 | 10 associated lipids |
| Abscess | D000038 | 13 associated lipids |
| Burns | D002056 | 34 associated lipids |
| Arthritis | D001168 | 41 associated lipids |
| Psoriasis | D011565 | 47 associated lipids |
| Edema | D004487 | 152 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
| Location | Cross reference | Weighted score | Related literatures |
|---|
| Function | Cross reference | Weighted score | Related literatures |
|---|
There are no associated biomedical information in the current reference collection.
There are no associated biomedical information in the current reference collection.
There are no associated biomedical information in the current reference collection.
| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Quiñones OG et al. | In vitro and in vivo influence of penetration enhancers in the topical application of celecoxib. | 2014 | Drug Dev Ind Pharm | pmid:23826859 |
| Madheswaran T et al. | Enhanced topical delivery of finasteride using glyceryl monooleate-based liquid crystalline nanoparticles stabilized by cremophor surfactants. | 2014 | AAPS PharmSciTech | pmid:24222268 |
| Morsi NM et al. | Silver sulfadiazine based cubosome hydrogels for topical treatment of burns: development and in vitro/in vivo characterization. | 2014 | Eur J Pharm Biopharm | pmid:23688805 |
| Esposito E et al. | Effect of nanostructured lipid vehicles on percutaneous absorption of curcumin. | 2014 | Eur J Pharm Biopharm | pmid:24361485 |
| Kolev VL et al. | Unit cell structure of water-filled monoolein into inverted hexagonal (H(II)) mesophase modeled by molecular dynamics. | 2014 | J Phys Chem B | pmid:24787641 |
| Ghattas N et al. | Monoolein production by triglycerides hydrolysis using immobilized Rhizopus oryzae lipase. | 2014 | Int. J. Biol. Macromol. | pmid:24755261 |
| Oliveira AC et al. | Dioctadecyldimethylammonium:monoolein nanocarriers for efficient in vitro gene silencing. | 2014 | ACS Appl Mater Interfaces | pmid:24712543 |
| Bitan-Cherbakovsky L et al. | Reversed hexagonal lyotropic liquid-crystal and open-shell glycodendrimers as potential vehicles for sustained release of sodium diclofenac. | 2014 | J Phys Chem B | pmid:24617448 |
| Tiossi RF et al. | In vitro and in vivo evaluation of the delivery of topical formulations containing glycoalkaloids of Solanum lycocarpum fruits. | 2014 | Eur J Pharm Biopharm | pmid:24509413 |
| Réeff J et al. | Characterization and optimization of GMO-based gels with long term release for intraarticular administration. | 2013 | Int J Pharm | pmid:23651644 |